An expert discusses treatments for narcolepsy, comparing options for managing excessive daytime sleepiness (EDS) and cataplexy, and examines the advantages, limitations, and clinical scenarios for ...
The drug is approved for the treatment of cataplexy or excessive daytime sleepiness (EDS) in narcolepsy patients. Lumryz has a boxed warning as a central nervous system depressant, and for its ...
Read on for her answers to frequently asked questions about managing sleep attacks. Cataplexy is the least common symptom of these, and many people with narcolepsy never experience it. Narcolepsy ...
Hosted on MSN10mon
Axsome's (AXSM) Narcolepsy Drug Study Meets Primary GoalThe study achieved its primary endpoint of a rapid and significant reduction in weekly cataplexy events. Data from the study showed that treatment with AXS-12 reduced cataplexy attacks by 83% over ...
This is cataplexy. Strong emotions like excitement, surprise, and anger can set it off. At other times, you may experience sleep paralysis, which is like cataplexy. You temporarily can't speak or ...
An expert discusses how key symptoms of narcolepsy, such as excessive daytime sleepiness and cataplexy, impact daily functioning and quality of life, along with the primary differences between type 1 ...
In the same 2020 study, researchers found that: 66% of participants with narcolepsy reported falling asleep while driving 29% experienced cataplexy while driving 12% experienced sleep paralysis ...
In addition to excessive daytime sleepiness, up to 60% of narcolepsy cases include cataplexy, which is a sudden loss of muscle control. When patients experience intense emotion, either positive or ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results